Cryoport Inc., a global provider of products and services to the cell and gene therapy industry, has entered into a strategic partnership with Cell and Gene Therapy Catapult, a company specializing in the advancement of cell and gene therapies, under which Cryoport Systems will establish its first global supply chain logistics center in the UK. The GMP-compliant facility will be located at CGT Catapult’s large-scale cell and gene therapy Stevenage Manufacturing Innovation Centre. The partners...